Route 92 Medical Files Patent Infringement Suit Against Balt
SAN MATEO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated...
Clinical Trial
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Topline results for the Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism on track for Q3 2025 Imapextide (MBX 1416)...
Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety
Where Is the DEA? The Real Threat Isn't Research-It's Rotten Weed."This is the height of hypocrisy," said Duane Boise, CEO...
Clinical Trial Site Feasibility: from 6 Months to Minutes with Research Grid’s New Automation Tool
Research Grid (R.grid) launches new Site Feasibility solution to accelerate trial startups and expand global patient accessThe tool uses real-world...
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 /...
Colorado Eye Consultants Founding Owner Dr. Lance Forstot Named 5280 Magazine Top Doctor for 2025
LITTLETON, COLORADO / ACCESS Newswire / August 6, 2025 / Colorado Eye Consultants is proud to announce that founding owner...
Eko Health Expands Clinical Advisory Board to Advance AI-Powered Disease Detection
Expansion brings together top clinical leaders to help scale Eko's disease detection platform following major FDA clearances, reimbursement wins, and...
Advarra Expands Its Study Collaboration Solution with Novel Site-Centered Technology to Improve Study Startup
Second 2025 Release Unveils a First-of-Its-Kind Site-Facing Milestone Tracker to Streamline Site Activation, Drive Transparency, and Strengthen Site Alignment with Sponsors...
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer
MyBladderCancerTeam and MyEndometrialCancer Team connect oncology patients with medically reviewed online content and support SAN FRANCISCO, Aug. 6, 2025 /PRNewswire/...
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring...
Cryoport Reports Second Quarter 2025 Financial Results
Second quarter revenue increased 14% year-over-year to $45.5 millionCommercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 millionLife...
Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions
New venture harnesses multi-omic data and AI to develop the largest platform on complex chronic illnesses to drive breakthroughs in POTS,...
Carta Healthcare Honored as Silver Stevie® Award Winner in 2025 Stevie Awards for Technology Excellence
SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- Carta Healthcare, a leading provider of AI-powered clinical data abstraction, has been named...
VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers
Multi-disciplinary cancer center joins VieCure's intelligent care ecosystem, bringing advanced precision oncology capabilities to the Pacific Northwest DENVER, CO /...
HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach
BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in...
Revolo Accelerates Development of Orally Administered ‘1104 for Allergic Diseases
‘1104 sublingual formulation achieved extensive systemic exposure and demonstrated impact across measures of disease in additional preclinical studies in atopic...
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
Targeting Multi-Chain Digital Asset Growth and Decentralized Finance (DeFi) Integration SARASOTA, FL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma,...
Senti Bio Determines Recommended Phase 2 Dose (RP2D) in Phase 1 Study of SENTI-202 for the Treatment of Relapsed/Refractory Hematologic Malignancies, Including Acute Myeloid Leukemia
Continued progress positions Company to report topline data for Phase 1 clinical trial of SENTI-202 before year-endSOUTH SAN FRANCISCO, Calif.,...
Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Aug....